BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

708 related articles for article (PubMed ID: 18949358)

  • 21. Integrin-linked kinase expression increases with ovarian tumour grade and is sustained by peritoneal tumour fluid.
    Ahmed N; Riley C; Oliva K; Stutt E; Rice GE; Quinn MA
    J Pathol; 2003 Oct; 201(2):229-37. PubMed ID: 14517840
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Activated Akt signaling pathway in invasive ductal carcinoma of the breast: correlation with HER2 overexpression.
    Park SS; Kim SW
    Oncol Rep; 2007 Jul; 18(1):139-43. PubMed ID: 17549359
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Role of PI3K and AKT specific isoforms in ovarian cancer cell migration, invasion and proliferation through the p70S6K1 pathway.
    Meng Q; Xia C; Fang J; Rojanasakul Y; Jiang BH
    Cell Signal; 2006 Dec; 18(12):2262-71. PubMed ID: 16839745
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitory effect of luteolin on hepatocyte growth factor/scatter factor-induced HepG2 cell invasion involving both MAPK/ERKs and PI3K-Akt pathways.
    Lee WJ; Wu LF; Chen WK; Wang CJ; Tseng TH
    Chem Biol Interact; 2006 Mar; 160(2):123-33. PubMed ID: 16458870
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of nm23-H1 in the progression of transitional cell bladder cancer.
    Chow NH; Liu HS; Chan SH
    Clin Cancer Res; 2000 Sep; 6(9):3595-9. PubMed ID: 10999750
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Protein chip discovery of secreted proteins regulated by the phosphatidylinositol 3-kinase pathway in ovarian cancer cell lines.
    Moscova M; Marsh DJ; Baxter RC
    Cancer Res; 2006 Feb; 66(3):1376-83. PubMed ID: 16452192
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Suppression of anoikis by SKP2 amplification and overexpression promotes metastasis of esophageal squamous cell carcinoma.
    Wang XC; Wu YP; Ye B; Lin DC; Feng YB; Zhang ZQ; Xu X; Han YL; Cai Y; Dong JT; Zhan QM; Wu M; Wang MR
    Mol Cancer Res; 2009 Jan; 7(1):12-22. PubMed ID: 19147533
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association between Nm23-H1 gene expression and metastasis of ovarian carcinoma.
    Gao QL; Ma D; Meng L; Wang SX; Wang CY; Lu YP; Zhang AL; Li J
    Ai Zheng; 2004 Jun; 23(6):650-4. PubMed ID: 15191664
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Expression of nm23-H1 gene product in sarcomatous cancer cells of renal cell carcinoma: correlation with tumor stage and expression of matrix metalloproteinase-2, matrix metalloproteinase-9, sialyl Lewis X, and c-erbB-2.
    Ohba K; Miyata Y; Koga S; Kanda S; Kanetake H
    Urology; 2005 May; 65(5):1029-34. PubMed ID: 15882758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Phosphatidylinositol 3-kinase/Akt pathway regulates inflammatory mediators-induced calcification of human vascular smooth muscle cells.
    Okazaki H; Shioi A; Hirowatari K; Koyama H; Fukumoto S; Ishimura E; Nishizawa Y
    Osaka City Med J; 2009 Dec; 55(2):71-80. PubMed ID: 20088406
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Phosphatidylinositol 3-kinase/Akt regulates the balance between plasminogen activator inhibitor-1 and urokinase to promote migration of SKOV-3 ovarian cancer cells.
    Whitley BR; Beaulieu LM; Carter JC; Church FC
    Gynecol Oncol; 2007 Feb; 104(2):470-9. PubMed ID: 17070899
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
    Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
    Hum Pathol; 2006 Aug; 37(8):1022-31. PubMed ID: 16867865
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Apigenin inhibits HGF-promoted invasive growth and metastasis involving blocking PI3K/Akt pathway and beta 4 integrin function in MDA-MB-231 breast cancer cells.
    Lee WJ; Chen WK; Wang CJ; Lin WL; Tseng TH
    Toxicol Appl Pharmacol; 2008 Jan; 226(2):178-91. PubMed ID: 17961621
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased staining for phosphorylated AKT and nuclear factor-kappaB p65 and their relationship with prognosis in epithelial ovarian cancer.
    Guo RX; Qiao YH; Zhou Y; Li LX; Shi HR; Chen KS
    Pathol Int; 2008 Dec; 58(12):749-56. PubMed ID: 19067848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Nm23-H1 promotes adhesion of CAL 27 cells in vitro.
    Bago R; Pavelić J; Maravić Vlahovicek G; Bosnar MH
    Mol Carcinog; 2009 Sep; 48(9):779-89. PubMed ID: 19263457
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Down-regulation of phosphatidylinositol 3'-kinase/AKT/molecular target of rapamycin metabolic pathway by primary letrozole-based therapy in human breast cancer.
    Generali D; Fox SB; Brizzi MP; Allevi G; Bonardi S; Aguggini S; Milani M; Bersiga A; Campo L; Dionisio R; Vergoni F; Giardini R; Dogliotti L; Bottini A; Harris AL; Berruti A
    Clin Cancer Res; 2008 May; 14(9):2673-80. PubMed ID: 18451231
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Correlation of MDR-1, nm23-H1 and H Sema E gene expression with histopathological findings and clinical outcome in ovarian and breast cancer patients.
    Galani E; Sgouros J; Petropoulou C; Janinis J; Aravantinos G; Dionysiou-Asteriou D; Skarlos D; Gonos E
    Anticancer Res; 2002; 22(4):2275-80. PubMed ID: 12174914
    [TBL] [Abstract][Full Text] [Related]  

  • 38. nm23-H1 gene expression in ovarian tumors--a potential tumor marker.
    Kapitanovic S; Spaventi R; Vujsic S; Petrovic Z; Kurjak A; Pavelic ZP; Gluckman JL; Stambrook PJ; Pavelic K
    Anticancer Res; 1995; 15(2):587-90. PubMed ID: 7763042
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of nm23-H1 in uveal melanoma.
    Bakalian S; Marshall JC; Faingold D; Logan P; Antecka E; Burnier MN
    Melanoma Res; 2007 Oct; 17(5):284-90. PubMed ID: 17885583
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Kalopanaxsaponin A inhibits PMA-induced invasion by reducing matrix metalloproteinase-9 via PI3K/Akt- and PKCdelta-mediated signaling in MCF-7 human breast cancer cells.
    Park SK; Hwang YS; Park KK; Park HJ; Seo JY; Chung WY
    Carcinogenesis; 2009 Jul; 30(7):1225-33. PubMed ID: 19420016
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.